Cryptococcosis: Clinical Trials

4 trials for Cryptococcosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Cryptococcosis: new trials by email Literature Review of Cryptococcosis trials Research Report on Cryptococcosis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Operational Research for Cryptococcal Antigen Screening
Fluconazole - Cryptococcal Meningitis, Cryptococcus Neoformans
Phase 4CompletedUniversity of Minnesota30492012-07-012020-06-04
Cryptococcal Optimal ART Timing Trial
efavirenz, nucleoside - Cryptococcal Meningitis, HIV Infections
Phase 4CompletedUniversity of Minnesota1772010-11-012020-06-09
Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Early antiretroviral therapy - Cryptococcal Meningitis, HIV Infections
Phase 4CompletedBotswana-UPenn Partnership282009-09-012012-02-07
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
Voriconazole - Candidiasis, Cryptococcosis
Phase 4CompletedPfizer72003-04-012011-05-16

Narrower conditions

Meningitis, Cryptococcal (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (2)  ·  Aspergillosis (1)  ·  Candidiasis (1)

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Infections (4)  ·  Mycoses (4)  ·  Blood-Borne Infections (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Fungal Infections (3)  ·  Central Nervous System Infections (3)  ·  Communicable Diseases (3)  ·  Genital Diseases (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)  ·  Lentivirus Infections (3)  ·  Meningitis (3)  ·  Meningitis, Fungal (3)  ·  Nervous System Diseases (3)

Interventions

Fluconazole (1)  ·  Lamivudine (1)  ·  Nucleosides (1)  ·  Stavudine (1)  ·  Voriconazole (1)  ·  Zidovudine (1)  ·  efavirenz (1)

Sponsors

University of Minnesota (2)  ·  Botswana-UPenn Partnership (1)  ·  Pfizer (1)

Countries

Uganda (2)  ·  Botswana (1)  ·  South Africa (1)  ·  Taiwan (1)

Top investigators

David B Meya, MMed (1)  ·  David R Boulware, MD, MPH (1)  ·  Gregory P Bisson, MD,MSCE (1)  ·  Pablo Tebas, MD (1)  ·  Radha Rajasingham, MD (1)

Results publications

PMID 23362285, PMID 24963568, PMID 30325463, PMID 30399034, PMID 31319498, PMID 31504335, PMID 32843994, PMID 39972326

NIH funding

U01AI089244 (1), U01GH000517 (1)